Covid: the effectiveness of the Pfizer-Biontech vaccine confirmed

Ema confirms the efficacy of Comirnaty, the Pfizer-Biontech vaccine. According to the first data collected since its placing on the market, Pfizer-Biontech vaccine confirms its reliability characteristics. The European Medicines Agency (Ema) writes this in the first updated report on the vaccine. The benefits of Comirnaty (Pfizer-Biontech's vaccine name) in preventing Covid-19 continue to outweigh the risks.

No modification - concludes Ema - is recommended regarding use ". Meanwhile, the Ministry of Health makes it known that today they are registered 13.574 new positive cases (yesterday 14.372). The new deaths are 477 (yesterday 492). The discharged healed in the last 24 hours are 19.879 (yesterday 17.220). The overall positive cases continue to remain below 500, in fact today they are 467.824 (yesterday 474617).

The effectiveness of the vaccine, the data are irrefutable

Meanwhile, according to the international media, the anti-Covid vaccine from the American biotechnology company Novavax is 89,3 effective percent and protects against English variant of the Coronavirus. However, it offers a much lower degree of protection against South Africa.

This was announced by the same company underlining that it will immediately begin to develop another vaccine dedicated to the South African variant. It should also be remembered that Johnson & Johnson's Covid vaccine is 66 percent effective The data collected shows 85 percent efficacy in cases with severe symptoms. In the United States, the efficacy on moderate and severe cases is 72 percent.

Hungary approves a Chinese vaccine

Hungary has approved the Chinese anti-Covid vaccine Sinopharm. Budapest thus becomes the first capital of the EU to give the green light to the vaccine developed by the Chinese state pharmaceutical company of the same name. Last week Hungary was the first EU country to approve the Russian Sputnik V vaccine.